Palvella Therapeutics (PVLA) Change in Cash (2013 - 2026)
Palvella Therapeutics (PVLA) reported Change in Cash of $148.4 million for Q1 2026, up 1960.73% year-over-year from $7.2 million in Q1 2025, and up 2757.33% on a QoQ basis from -$5.6 million in Q4 2025.
Palvella Therapeutics (PVLA) has 14 years of Change in Cash data on file, last reported at $148.4 million in Q1 2026.
- Quarterly Change in Cash rose 1960.73% year-over-year to $148.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $130.8 million (up 88.49% YoY) and the FY2025 annual result came in at -$25.6 million, down 133.6% from the prior year.
- Change in Cash advanced to $148.4 million in Q1 2026 per PVLA's latest filing, from -$5.6 million in the prior quarter.
- Across five years, Change in Cash topped out at $148.4 million in Q1 2026 and bottomed at -$34.0 million in Q1 2022.
- The 5-year median for Change in Cash is -$5.2 million (2025), against an average of $6.5 million.
- The widest annual swing landed in 2024, when Change in Cash soared 2442.84%; it then slumped 1980.61% in 2025.
- Tracing PVLA's Change in Cash over 5 years: stood at -$9.8 million in 2022, then jumped by 69.74% to -$3.0 million in 2023, then soared by 2442.84% to $69.4 million in 2024, then slumped by 108.05% to -$5.6 million in 2025, then jumped by 2757.33% to $148.4 million in 2026.
- Per Business Quant, the three latest PVLA Change in Cash figures stand at $148.4 million (Q1 2026), -$5.6 million (Q4 2025), and -$6.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | 148.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148.41 Mn |
| Dec 31, 2025 | -5.59 Mn |
| Sep 30, 2025 | -6.87 Mn |
| Jun 30, 2025 | -5.19 Mn |
| Mar 31, 2025 | -7.98 Mn |
| Dec 31, 2024 | 69.40 Mn |
| Sep 30, 2024 | -330,000.00 |
| Jun 30, 2024 | 8.29 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | -2.96 Mn |
| Sep 30, 2023 | -12.04 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | -9.79 Mn |
| Sep 30, 2022 | -5.83 Mn |
| Jun 30, 2022 | -29.48 Mn |
| Mar 31, 2022 | -34.03 Mn |
| Dec 31, 2021 | -7.29 Mn |
| Sep 30, 2021 | 5.96 Mn |
| Jun 30, 2021 | 52.26 Mn |
| Mar 31, 2021 | -3.60 Mn |
| Dec 31, 2020 | 3.55 Mn |
| Sep 30, 2020 | 22.59 Mn |
| Jun 30, 2020 | -3.13 Mn |
| Mar 31, 2020 | -14.83 Mn |
| Dec 31, 2019 | 16.19 Mn |
| Sep 30, 2019 | -8.83 Mn |
| Jun 30, 2019 | 2.81 Mn |
| Mar 31, 2019 | -22.77 Mn |
| Dec 31, 2018 | -14.62 Mn |
| Sep 30, 2018 | 38.91 Mn |
| Jun 30, 2018 | -58.95 Mn |
| Mar 31, 2018 | 71.64 Mn |
| Dec 31, 2017 | -52.04 Mn |
| Sep 30, 2017 | 39.60 Mn |
| Jun 30, 2017 | -4.92 Mn |
| Mar 31, 2017 | 25.89 Mn |
| Dec 31, 2016 | -7.20 Mn |
| Sep 30, 2016 | -3.82 Mn |
| Jun 30, 2016 | 9.19 Mn |
| Mar 31, 2016 | 1.84 Mn |
| Dec 31, 2015 | -2.91 Mn |
| Sep 30, 2015 | 22.23 Mn |
| Jun 30, 2015 | -3.14 Mn |
| Mar 31, 2015 | -5.31 Mn |
| Sep 30, 2014 | 10,918.00 |
| Jun 30, 2014 | -2.20 Mn |
| Mar 31, 2014 | -419,503.00 |
| Dec 31, 2013 | 598.00 |
| Sep 30, 2013 | -4,512.00 |
| Jun 30, 2013 | 5,200.00 |